Prolonged-release oxycodone-naloxone for pain management in advanced EGFR wild-type lung cancer patients

被引：1
|
作者：
Stella, Giulia M. [1 ]
Piloni, Davide [2 ]
Ciuffreda, Antonio [1 ]
Spiaggi, Ernestina [1 ]
Marino, Elisa [1 ]
Ilardi, Marcella [3 ]
Cavalloro, Fabrizio [3 ]
机构：
[1] San Matteo Polyclin & Inst Res & Care, Sect Pneumol, Dept Cardiothorac Surg, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med, Unit Pneumol, Pavia, Italy
[3] San Matteo Polyclin & Inst Res & Care, Emergency Dept, Pain Unit, Pavia, Italy
来源：
MINERVA MEDICA | 2018年 / 109卷 / 04期
关键词：
D O I：
10.23736/S0026-4806.18.05287-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：337 / 340
页数：5
相关论文
共 50 条
  • [21] Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain
    Ahmedzai, Sam H.
    Leppert, Wojciech
    Janecki, Marcin
    Pakosz, Artur
    Lomax, Mark
    Duerr, Heike
    Hopp, Michael
    SUPPORTIVE CARE IN CANCER, 2015, 23 (03) : 823 - 830
  • [22] Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study
    Nolte, Thomas
    Schutter, Ulf
    Loewenstein, Oliver
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2014, 5 : 1 - 13
  • [23] Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
    Guerriero, Fabio
    Sgarlata, Carmelo
    Marcassa, Claudio
    Ricevuti, Giovanni
    Rollone, Marco
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 1 - 11
  • [24] Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation
    Burness, Celeste B.
    Keating, Gillian M.
    DRUGS, 2014, 74 (03) : 353 - 375
  • [25] Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation
    Celeste B. Burness
    Gillian M. Keating
    Drugs, 2014, 74 : 353 - 375
  • [26] Oral Prolonged-Release Oxycodone/Naloxone for Managing Pain and Opioid-Induced Constipation: A Review of the Evidence
    Morlion, Bart J.
    Mueller-Lissner, Stefan A.
    Vellucci, Renato
    Leppert, Wojciech
    Coffin, Benoit C.
    Dickerson, Sara L.
    O'Brien, Tony
    PAIN PRACTICE, 2018, 18 (05) : 647 - 665
  • [27] Efficacy and tolerability of transdermal fentanyl versus oral prolonged-release oxycodone/naloxone in patients with moderate to severe cancer pain: A propensity analysis comparison
    Roberto, A.
    Greco, M. T.
    Legramandi, L.
    Galli, F.
    Corli, O.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational studyle
    Hesselbarth, Sabine
    Loewenstein, Oliver
    Cegla, Thomas
    SCANDINAVIAN JOURNAL OF PAIN, 2014, 5 (02) : 75 - 81
  • [29] Prolonged-release oxycodone/naloxone in opioid-naive patients - subgroup analysis of a prospective observational study
    Hesselbarth, Sabine
    Hermanns, Kai
    Oepen, Petra
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 457 - 464
  • [30] Efficacy and safety of oral Prolonged-Release Oxycodone/Naloxone in opioid-naive cancer patients: results from GREAT study
    Legramandi, L.
    Rulli, E.
    Stupia, S. F.
    Roberto, A.
    Corli, O.
    ANNALS OF ONCOLOGY, 2016, 27
12345